INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 279 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,555,449 | -4.2% | 276,393 | +3.2% | 0.05% | 0.0% |
| Q2 2023 | $11,018,933 | +93.6% | 267,905 | +170.2% | 0.05% | +85.7% |
| Q1 2023 | $5,692,431 | -33.6% | 99,154 | -35.2% | 0.03% | -41.7% |
| Q4 2022 | $8,578,093 | -7.9% | 152,989 | -30.4% | 0.05% | -4.0% |
| Q3 2022 | $9,311,000 | +29.4% | 219,796 | +65.1% | 0.05% | +35.1% |
| Q2 2022 | $7,193,000 | +22.9% | 133,133 | +46.2% | 0.04% | +12.1% |
| Q1 2022 | $5,853,000 | +2204.3% | 91,088 | +2377.2% | 0.03% | +1550.0% |
| Q1 2021 | $254,000 | -95.4% | 3,677 | -95.7% | 0.00% | -95.7% |
| Q4 2020 | $5,561,000 | -5.7% | 85,658 | -31.4% | 0.05% | -4.1% |
| Q3 2020 | $5,896,000 | +555.1% | 124,859 | +552.2% | 0.05% | +390.0% |
| Q2 2020 | $900,000 | -41.7% | 19,145 | -44.6% | 0.01% | -77.3% |
| Q1 2020 | $1,544,000 | -31.2% | 34,574 | -10.2% | 0.04% | 0.0% |
| Q4 2019 | $2,243,000 | – | 38,487 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Champlain Investment Partners, LLC | 6,529,175 | $451,101,000 | 2.35% |
| Tributary Capital Management, LLC | 426,617 | $29,475,000 | 2.30% |
| COOKE & BIELER LP | 2,699,449 | $186,505,000 | 1.81% |
| Sapience Investments, LLC | 169,325 | $11,699,000 | 1.47% |
| Hood River Capital Management LLC | 439,731 | $30,381,000 | 0.98% |
| Monarch Partners Asset Management LLC | 82,608 | $5,707,000 | 0.86% |
| Mitsubishi UFJ Asset Management (UK) Ltd. | 23,400 | $1,617,000 | 0.72% |
| GW&K Investment Management, LLC | 725,691 | $50,138,000 | 0.46% |
| Olstein Capital Management, L.P. | 46,000 | $3,178,000 | 0.44% |
| Quantinno Capital Management LP | 5,088 | $352,000 | 0.38% |